See more : Christian Dior SE (CHDRF) Income Statement Analysis – Financial Results
Complete financial analysis of Intelligent Ultrasound Group plc (IUG.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Intelligent Ultrasound Group plc, a leading company in the Medical – Devices industry within the Healthcare sector.
- Health Assurance Acquisition Corp. (HAACU) Income Statement Analysis – Financial Results
- Lumos Pharma, Inc. (LUMO) Income Statement Analysis – Financial Results
- The South Indian Bank Limited (SOUTHBANK.BO) Income Statement Analysis – Financial Results
- GSS Infotech Limited (GSS.BO) Income Statement Analysis – Financial Results
- BlackRock Municipal Income Fund, Inc. (MUI) Income Statement Analysis – Financial Results
Intelligent Ultrasound Group plc (IUG.L)
About Intelligent Ultrasound Group plc
Intelligent Ultrasound Group plc, through its subsidiaries, develops, markets, and distributes medical training simulators and clinical ultrasound software in the United Kingdom, North America, and internationally. It provides ScanNav Assist, an AI-based ultrasound software products that provide real-time image analysis during protocol-based scanning in the women's health sector; ScanNav Anatomy Peripheral Nerve Block (PNB), an AI based ultrasound software, which can automatically identify and highlight key anatomical structures in a live ultrasound image; and ScanNav Detect, which facilitate the automatic recognition of abnormalities within a general medical ultrasound scan. The company also offers ScanNav HealthCheck, an ultrasound software products that aims to enable ultrasound scans to be performed at home; ScanTrainer, an educational tool that uses real patient scans and curriculum-based teaching across obstetrics, gynecology, general medicine, and emergency medicine; ScanNav Anatomy PNB Trainer to teach ultrasound-guided needling to medical professionals; BodyWorks Eve, an ultra-realistic female patient simulator designed for interactive?point of care ultrasound scenario training; and NeedleTrainer, an augmented reality needling for non-invasive, safe, and realistic ultrasound-guided needling training. In addition, it provides BabyWorks, a baby manikin training tool for point of care ultrasound and echocardiography in pediatric and neonatal care; HeartWorks, a highly realistic simulator with all the tools needed to learn echocardiography; BodyWorks, a hi-fidelity simulator used in critical care, intensive care, and emergency medicine; and ORSIM, a simulator designed to teach advanced bronchoscopy skills in a virtual environment. The company was formerly known as MedaPhor Group plc and changed its name to Intelligent Ultrasound Group plc in January 2019. Intelligent Ultrasound Group plc was founded in 2004 and is headquartered in Cardiff, the United Kingdom.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.17M | 10.10M | 7.60M | 5.17M | 5.92M | 5.31M | 4.18M | 3.29M | 2.21M | 1.80M | 1.35M | 731.00K | 362.00K |
| Cost of Revenue | 4.33M | 3.77M | 2.94M | 2.00M | 2.46M | 2.48M | 1.66M | 1.17M | 766.94K | 679.41K | 529.00K | 148.00K | 101.00K |
| Gross Profit | 6.84M | 6.33M | 4.66M | 3.17M | 3.45M | 2.83M | 2.52M | 2.11M | 1.44M | 1.12M | 823.00K | 583.00K | 261.00K |
| Gross Profit Ratio | 61.21% | 62.71% | 61.33% | 61.33% | 58.38% | 53.33% | 60.35% | 64.27% | 65.26% | 62.34% | 60.87% | 79.75% | 72.10% |
| Research & Development | 0.00 | 3.20M | 3.23M | -83.00K | 2.04M | 1.34M | 966.65K | 621.67K | 548.42K | 404.55K | 214.52K | 0.00 | 0.00 |
| General & Administrative | 9.87M | 10.01M | 8.99M | 7.86M | 8.17M | 7.12M | 5.23M | 3.90M | 3.11M | 2.63M | 1.22M | 723.00K | 572.00K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 9.87M | 10.01M | 8.99M | 7.86M | 8.17M | 7.12M | 5.23M | 3.90M | 3.11M | 2.63M | 1.22M | 723.00K | 572.00K |
| Other Expenses | -9.00K | -8.00K | -2.00K | 0.00 | -157.31K | -310.48K | -28.23K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 9.86M | 10.01M | 8.99M | 7.78M | 8.01M | 6.81M | 5.20M | 3.90M | 3.11M | 2.63M | 1.22M | 723.00K | 572.00K |
| Cost & Expenses | 14.19M | 13.77M | 11.93M | 9.78M | 10.47M | 9.29M | 6.86M | 5.07M | 3.88M | 3.31M | 1.75M | 871.00K | 673.00K |
| Interest Income | 26.00K | 1.00K | 1.00K | 17.00K | 2.00K | 7.40K | 7.83K | 3.34K | 1.66K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 29.00K | 31.00K | 37.00K | 17.00K | 2.00K | 7.40K | 7.83K | 3.34K | 1.66K | 3.53K | 0.00 | 16.00K | 4.00K |
| Depreciation & Amortization | 1.62M | 1.38M | 1.19M | 1.34M | 1.37M | 1.24M | 1.03M | 563.01K | 465.22K | 271.82K | 174.00K | 34.00K | 14.00K |
| EBITDA | -1.38M | -2.29M | -3.14M | -3.33M | -3.34M | -2.74M | -4.55M | -1.92M | -1.21M | -1.23M | -221.00K | -106.00K | -297.00K |
| EBITDA Ratio | -12.34% | -22.64% | -41.38% | -62.77% | -53.82% | -51.55% | -119.11% | -37.20% | -54.60% | -68.36% | -16.35% | -14.50% | -82.04% |
| Operating Income | -3.02M | -3.67M | -4.33M | -4.61M | -4.56M | -3.61M | -5.54M | -2.48M | -1.67M | -1.51M | -395.00K | -140.00K | -311.00K |
| Operating Income Ratio | -27.03% | -36.36% | -57.03% | -89.07% | -77.05% | -68.02% | -132.47% | -75.59% | -75.67% | -83.43% | -29.22% | -19.15% | -85.91% |
| Total Other Income/Expenses | -3.00K | -30.00K | -36.00K | 0.00 | -2.00K | -7.40K | -7.83K | -3.34K | -1.66K | -3.53K | 94.00 | -16.00K | -4.00K |
| Income Before Tax | -3.02M | -3.70M | -4.37M | -4.48M | -4.56M | -3.62M | -5.55M | -2.49M | -1.67M | -1.51M | -395.00K | -156.00K | -315.00K |
| Income Before Tax Ratio | -27.06% | -36.65% | -57.50% | -86.67% | -77.08% | -68.16% | -132.65% | -75.69% | -75.75% | -83.62% | -29.22% | -21.34% | -87.02% |
| Income Tax Expense | -441.00K | -718.00K | -758.00K | -1.18M | -337.52K | -203.80K | -127.61K | -73.20K | -42.18K | -19.75K | -66.00K | 0.00 | -20.00K |
| Net Income | -2.58M | -2.98M | -3.61M | -3.31M | -4.22M | -3.42M | -5.42M | -2.41M | -1.63M | -1.49M | -329.00K | -156.00K | -295.00K |
| Net Income Ratio | -23.11% | -29.54% | -47.53% | -63.95% | -71.38% | -64.32% | -129.60% | -73.46% | -73.84% | -82.53% | -24.33% | -21.34% | -81.49% |
| EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.04 | -0.12 | -0.09 | -0.08 | -0.11 | -0.02 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.04 | -0.12 | -0.09 | -0.08 | -0.11 | -0.02 | -0.01 | -0.01 |
| Weighted Avg Shares Out | 326.88M | 275.27M | 269.96M | 254.92M | 178.50M | 95.23M | 46.29M | 27.35M | 20.14M | 14.02M | 20.12M | 20.12M | 20.12M |
| Weighted Avg Shares Out (Dil) | 326.87M | 275.27M | 269.96M | 254.92M | 178.50M | 95.23M | 46.29M | 27.35M | 20.14M | 14.02M | 20.12M | 20.12M | 20.12M |
Source: https://incomestatements.info
Category: Stock Reports